Related Experiment Video
Updated: May 21, 2026
07:11
Constructing Cyclic Peptides Using an On-Tether Sulfonium Center
Published on: September 28, 2022
Improving the Fmoc Solid Phase Synthesis of the Cyclic Hexapeptide Complement C5a Antagonist, PMX205
R C Delisle Milton1, S C Milton, A R Chamberlin
1Department of Pharmaceutical Sciences, University of California at Irvine, Irvine, CA 92697, USA.
Summary
PMX205, an anti-inflammatory drug, shows promise for neurodegenerative diseases. Optimized synthesis using 2-chlorotrityl resin and FDPP coupling significantly improved yields for this cyclic hexapeptide.
Area of Science:
- Medicinal Chemistry
- Neuroscience
- Immunology
Background:
- PMX205 is a C5a complement receptor antagonist with demonstrated efficacy in rodent models of neurodegenerative diseases like ALS and Alzheimer's.
- The synthesis of the cyclic hexapeptide PMX205 has been challenging, yielding low amounts in both solution and solid-phase methods.
- Previous attempts at solid-phase synthesis encountered significant substitution loss, hindering efficient production.
Purpose of the Study:
- To optimize the solid-phase synthesis of the cyclic hexapeptide PMX205.
- To improve the yield of both peptide assembly and cyclization steps.
- To identify commercially available reagents that enhance PMX205 production.
Main Methods:
- Utilized 2-chlorotrityl resin to mitigate substitution loss during solid-phase peptide assembly.
- Employed pentafluorophenyl diphenylphosphinate (FDPP) coupling at high dilution for the cyclization step.
- Focused on optimizing existing, commercially available reagents and methodologies.
Main Results:
- The use of 2-chlorotrityl resin effectively prevented or reduced catastrophic substitution loss during solid-phase synthesis.
- Employing FDPP at high dilution significantly improved the cyclization reaction yield, reaching up to 80% purified product.
- Both optimized methods utilize readily available commercial products, facilitating potential scale-up.
Conclusions:
- The optimized solid-phase synthesis strategy significantly enhances the production yield of PMX205.
- The use of 2-chlorotrityl resin and FDPP coupling represents a practical advancement for synthesizing this neuroprotective cyclic hexapeptide.
- These improvements offer a more efficient and accessible route for producing PMX205 for further research and therapeutic development.
